| KY | HB477 | Pass | Creates a new section of KRS Chapter 205 to establish diagnosis criteria for sepsis.
[Detail][Text][Discuss] | 2024-04-09
signed by Governor (Acts Ch. 125) |
| KY | HB115 | Pass | Amends KRS 18A.225 and 164.2871 to require the state employee health plan and self-insured employer group health plans provided by the governing board of a state postsecondary education institution to comply with breast examination coverage requireme...
[Detail][Text][Discuss] | 2024-04-05
signed by Governor (Acts Ch. 97) |
| KY | HB52 | Pass | Creates a new section of Subtitle 17A of KRS Chapter 304 to define “cancer screening, test, or procedure,” and to require coverage for certain cancer screenings, tests, and procedures; and amends KRS 18A.225, 164.2871, and 205.522 to require Medi...
[Detail][Text][Discuss] | 2024-04-04
signed by Governor (Acts Ch. 75) |
| KY | HB438 | Intro
Sine Die | Amend KRS 158.832 to include a definition for "undesignated glucagon"; amend KRS 158.838 to allow health care practitioners to prescribe undesignated glucagon in the name of a school to be maintained for use by a school nurse or trained school employ...
[Detail][Text][Discuss] | 2024-03-27
To House Appropriations and Revenue Committee |
| KY | HB274 | Pass | Amends KRS 315.010 and 315.205 to permit pharmacists to administer vaccines to children five years of age or older pursuant to prescriber-approved protocols with the consent of a parent or guardian.
[Detail][Text][Discuss] | 2024-03-26
signed by Governor (Acts Ch.11) |
| KY | HB328 | Engross
Sine Die | Amend KRS 258.005 to define "veterinarian" and "veterinary technician"; amend KRS 258.015 to authorize a Kentucky licensed veterinary technician to vaccinate a dog, cat, or ferret against rabies.
[Detail][Text][Discuss] | 2024-03-08
To Senate Committee on Committees |
| KY | HB618 | Engross
Sine Die | Amend KRS 510.320 to define "sexually transmitted disease"; set requirements for tests for a sexually transmitted disease rather than human immunodeficiency virus; amend KRS 529.090 to define "sexually transmitted disease"; set requirements for tests...
[Detail][Text][Discuss] | 2024-03-08
To Senate Health Services Committee |
| KY | HB642 | Intro
Sine Die | Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for coronary calcium imaging testing; provide that coronary calcium imaging testing shall not be considered investigational or experimental; a...
[Detail][Text][Discuss] | 2024-02-22
To House Committee On Committees |
| KY | HB617 | Intro
Sine Die | Create new sections of KRS Chapter 210 to define terms; establish the Kentucky Youth Mobile Crisis Response Program within the Cabinet for Health and Family Services; set requirements for mobile crisis response teams; require the cabinet to develop p...
[Detail][Text][Discuss] | 2024-02-20
To House Committee On Committees |
| KY | HB352 | Intro
Sine Die | Amend KRS 218B.010 to add additional conditions to the list of qualifying medical conditions for the use of medicinal cannabis.
[Detail][Text][Discuss] | 2024-01-23
To House Committee On Committees |
| KY | HB322 | Intro
Sine Die | Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for the testing of hepatitis C virus infection in pregnant women and the treatment of hepatitis C virus infection in postpartum women; amend K...
[Detail][Text][Discuss] | 2024-01-22
To House Committee On Committees |
| KY | HB273 | Intro
Sine Die | Create a new section of KRS Chapter 205 to require the Department for Medicaid Services and any managed care organization contracted to provide Medicaid benefits to provide comprehensive coverage for the treatment of obesity and inform Medicaid enrol...
[Detail][Text][Discuss] | 2024-01-16
To House Committee On Committees |
| KY | HB229 | Intro
Sine Die | Create a new section of KRS 217.005 to 217.215, the Kentucky Food, Drug, and Cosmetic Act, to define terms; require products that are known to be or could act as gene therapy to be labeled with the words "Potential Gene Therapy Product" or "Gene Ther...
[Detail][Text][Discuss] | 2024-01-10
To House Committee On Committees |
